foxo4-dri senolytic peptide human trial The disordered p53 transactivation domain is the target of FOXO4 and the compound Tailor Made Compounding — Number of Vials:2 Vials (Differentiated Results) Form_Tablets
Pay in 4 interest-free payments of $6.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14